McKesson Corporation

McKesson Corporation: Will Its Cost Optimization & Operational Efficiencies Help Alter The Playing Field? - Major Drivers - Smartkarma
McKesson Corporation (NYSE:MCK) Q2 2025 Earnings Call Transcript - Insider Monkey
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Marketscreener.com
McKesson Corporation Reports Strong Q2 Earnings Growth - TipRanks
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Yahoo Finance
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - businesswire.com
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
McKesson Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now? - Insider Monkey
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now? - Yahoo Finance UK
Is McKesson Corporation (MCK) the Best Pharma Stock to Buy Right Now? - Yahoo Finance
With 88% ownership of the shares, McKesson Corporation (NYSE:MCK) is heavily dominated by institutional owners - Simply Wall St
McKesson Corporation Declares Quarterly Dividend - StockTitan
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock - MSN
Is McKesson Corporation (NYSE:MCK) the Most Undervalued Value Stock to Buy According to Analysts? - Insider Monkey
Desktop versie